Pioneering Bioelectronic Medicine

SetPoint Medical is dedicated to treating patients with debilitating inflammatory diseases, such as Crohn’s Disease and rheumatoid arthritis, using proprietary implantable bioelectronic devices. Early clinical data suggests SetPoint’s bioelectronic therapy is well tolerated and can treat patients that fail to respond to biologics or have become refractory to biologics.

Bioelectronic medicine uses small implanted devices to deliver targeted electrical pulses along existing physiologic pathways to trigger the body’s biological responses, creating a systemic disease-fighting effect. It is designed to provide ‘built-in’ therapy at a lower cost and is intended to improve safety compared with drugs or biologic solutions. The company successfully completed a trial in rheumatoid arthritis which was published in the Proceedings of the National Academy of Sciences in 2016 and is currently conducting human trials in Crohn’s disease in multiple European centers.

SetPoint intends to develop bioelectronic medicine therapy as a breakthrough approach to treating autoimmune inflammatory diseases.

SetPoint’s Leadership

Anthony Arnold
Chief Executive Officer
Anthony Arnold was formerly a VP of Marketing at Boston Scientific and worked in development and marketing roles at Medtronic and Smith+Nephew. He has 20 years of medical device experience, including 5 years as a senior consultant to leading device companies.
Mike Faltys
Chief Technical Officer
Mike Faltys was formerly a VP of Engineering at Advanced Bionics. He has over 15 years of experience in active implantable devices and over 10 years of supercomputer architecture.
Ralph Zitnik, MD
Chief Medical Officer
Ralph Zitnik was formerly the Therapeutic Area Head at Amgen/Immunex (Enbrel). He has also worked for Pfizer and Bayer, has over 10 years of clinical medicine and inflammation research experience at Yale, and over 15 years of biomedical industry experience.
Allan Will
Allan Will is currently CEO of EBR. He was the former CEO & Founder of The Foundry, the former Chairman of Ardian, and a Managing Director at Split R.